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Prospective study of alcohol consumption and the incidence of the
metabolic syndrome in US men
Abstract
Few studies have evaluated the effects of alcohol consumption on the incidence of the metabolic syndrome
(MetS). Therefore, the objective of the present study was to examine the association between alcohol
consumption and incident MetS in a population of US men. This is a prospective study of 7483 Caucasian
men, who were free of the MetS and CVD at baseline. Information was collected on alcohol consumption,
health status and fitness level at an initial clinical examination. Additional health information and
determination of incident cases of the MetS were obtained at follow-up clinical examinations between 1979
and 2005. Compared with non-drinkers, the multivariate hazard ratios of the MetS for light (1–3 drinks/
week), moderate (4–7 drinks/week), moderate–heavy (8–13 drinks/week) and heavy ( ≥ 14 drinks/week)
drinkers were 0·81 (95 % CI 0·68, 0·95), 0·68 (95 % CI 0·57, 0·80), 0·70 (95 % CI 0·59, 0·83) and 0·78 (95 %
CI 0·66, 0·91), respectively. This association was seen across age groups, in men with one or more pre-existing
MetS risk factors, and those with BMI ≥ 25 kg/m2, and in all alcohol beverage types at most levels of alcohol
consumption. An inverse dose–response association between alcohol consumption and low HDL
concentrations was observed, while significant associations were observed between high fasting glucose
concentrations and moderate, moderate–heavy and heavy levels of alcohol consumption. Alcohol
consumption was not significantly associated with central obesity, hypertriacylglycerolaemia or hypertension.
All levels of alcohol consumption provided significant inverse associations with incidence of the MetS. In
particular, this effect was observed in overweight and/or obese individuals, in those who had pre-existing risk
factors for the MetS, and extended across all types of alcoholic beverages consumed.
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Abstract
Few studies have evaluated the effects of alcohol consumption on the incidence of the metabolic syndrome (MetS). Therefore,
the objective of the present study was to examine the association between alcohol consumption and incident MetS in a population of
US men. This is a prospective study of 7483 Caucasian men, who were free of the MetS and CVD at baseline. Information was collected
on alcohol consumption, health status and fitness level at an initial clinical examination. Additional health information and determination of
incident cases of the MetS were obtained at follow-up clinical examinations between 1979 and 2005. Compared with non-drinkers, the
multivariate hazard ratios of the MetS for light (1–3 drinks/week), moderate (4–7 drinks/week), moderate–heavy (8–13 drinks/week)
and heavy ($14 drinks/week) drinkers were 0·81 (95 % CI 0·68, 0·95), 0·68 (95 % CI 0·57, 0·80), 0·70 (95 % CI 0·59, 0·83) and 0·78
(95 % CI 0·66, 0·91), respectively. This association was seen across age groups, in men with one or more pre-existing MetS risk factors,
and those with BMI $25 kg/m2, and in all alcohol beverage types at most levels of alcohol consumption. An inverse dose–response associ-
ation between alcohol consumption and low HDL concentrations was observed, while significant associations were observed between
high fasting glucose concentrations and moderate, moderate–heavy and heavy levels of alcohol consumption. Alcohol consumption
was not significantly associated with central obesity, hypertriacylglycerolaemia or hypertension. All levels of alcohol consumption provided
significant inverse associations with incidence of the MetS. In particular, this effect was observed in overweight and/or obese individuals, in
those who had pre-existing risk factors for the MetS, and extended across all types of alcoholic beverages consumed.
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The metabolic syndrome (MetS) is a constellation of metabolic
abnormalities that includes central obesity, low HDL
concentrations, high fasting glucose and TAG concentrations,
and elevated blood pressure (BP), which is fast becoming a
major public health challenge(1). This combination of
cardiometabolic risk factors has received an increasing level
of attention due to its strong association with the development
of diabetes and increased risk of cardiovascular morbidity and
mortality(2,3). According to Ford et al.(4), the age-adjusted preva-
lence of the MetS in the US population is 23 %, yet many of the
mechanisms underlying its development remain unknown.
Given the prevalence of the MetS, there is increasing import-
ance to obtain a greater understanding of the modifiable factors
that may mitigate or moderate the progression of events leading
towards its development.
Among these modifiable factors, there has only recently been
interest in examining the effect of alcohol consumption on the
development of the MetS. Alcohol consumption is an accepted
part of the American culture, as an estimated 76 % of American
men engage in alcohol consumption over the course of a year,
with 33 % of men reporting alcohol consumption on any given
day(5). Previous studies have established strong evidence for a
reduced risk of CHD(6), stroke(7) and mortality(8) with light-to-
moderate levels of alcohol consumption, with heavier levels
of consumption resulting in negative health consequences.
Moderate-to-high levels of alcohol consumption have been
*Corresponding author: Professor M. Stoutenberg, fax þ1 305 243 3651, email mstoutenberg@med.miami.edu
Abbreviations: BP, blood pressure; HDL-C, HDL-cholesterol; HR, hazard ratio; MetS, metabolic syndrome.
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associated with hypertension, liver disease, peptic ulcers,
certain types of cancers, pregnancy complications and brain
damage(9).
Given the popularity of alcohol and its diverse effects on
health and chronic disease, it is important to obtain a clearer
understanding of its association with the MetS. The extent of
this association is controversial as the existing literature is
filled with conflicting findings. A recent meta-analysis con-
cluded that light-to-moderate drinking provides a beneficial
metabolic effect(10). However, individual studies have described
the relationship between alcohol consumption and the MetS as
being J-shaped(11), U-shaped(12), an inverse relationship(13,14), a
linear relationship(15,16) or having no relationship at all(17,18).
Yet, only a handful of these studies have prospectively exam-
ined alcohol consumption and the incidence of the
MetS(16–20), and, of these, only two have been conducted in
North America(16,21). Contributing to this controversy, there
appear to be sex differences as have been found by investi-
gators: the prevalence of the MetS to be higher in women
than in men who abstained from drinking(13); a positive associ-
ation of alcohol consumption in women only(18); a similar effect
of moderate alcohol consumption in both sexes(11); no associ-
ation in either sex(17). A final weakness in previous studies
involves the adjustment for physical activity levels. Studies
examining the relationship between cardiorespiratory fitness
and the MetS have identified an inverse association(22), whereas
a study using self-reported physical activity exposure was
equivocal(23). Cardiorespiratory fitness is a stronger predictor
of health than self-reported physical activity, and may therefore
serve as a more accurate modifying variable(24).
Therefore, the purpose of the present study was to examine
the prospective association between alcohol consumption and
the incidence of the MetS in a population of US men, and to
determine whether this relationship is modified by cardiore-
spiratory fitness, BMI, age and baseline health status.
Experimental methods
Study population
Participants were 20–100-year-old men (mean 43·4 (SD 9·0)
years) who had preventive medical examinations at the
Cooper Clinic (Dallas, TX, USA) between 1979 and 2005 and
who were enrolled in the Aerobics Center Longitudinal Study.
Criteria for inclusion in the present analysis required individuals
to have had at least two clinical examinations with complete
measurements for each MetS variable and a baseline cardio-
respiratory fitness assessment (n 12 551). Individuals were
excluded based on pre-existing cases of the MetS (n 2419),
CVD (including heart attack or stroke), cancer or an abnormal
resting or exercise electrocardiogram (n 1282) at baseline. In
addition, those not achieving $85 % of age-predicted maximal
heart rate on the treadmill test at baseline (n 88) or who had less
than 1 year of follow-up (n 1279) were excluded. The remaining
7483 men met all criteria for the present study and were
included in the final analysis. The study was conducted accord-
ing to the guidelines laid down in the Declaration of Helsinki,
and all procedures involving human subjects/patients were
approved by the Cooper Institute Institutional Review Board.
Written informed consent was obtained from all subjects/
patients for the baseline clinical examination and follow-up
study.
Definition of the metabolic syndrome
The outcome variable of the MetS was defined, following the
guidelines of the National Cholesterol Education Program –
Adult Treatment Panel III (NCEP ATP III), as meeting three
or more of the following criteria: abdominal obesity (waist
circumference . 102 cm); TAG $15 mg/l; HDL-cholesterol
(HDL-C) ,4 mg/l; resting systolic or diastolic BP of $130 or
$85 mmHg, respectively; a fasting blood glucose $ 10 mg/
l(1). Self-reported history of physician-diagnosed hypertension
and diabetes was included in the definition of abnormal BP
and glucose, respectively, as done in other epidemiological
studies investigating the incidence of the MetS(21).
Alcohol exposure
At their initial clinical visit, as part of the Personal Habits section
of their Medical History Questionnaire, individuals were asked a
series of ten questions regarding their alcohol use, specifically
whether they drank alcoholic beverages and how many
drinks per week they consumed of beer, wine and hard
liquor. Alcohol consumption was quantified as the number of
drinks per week, with a drink standardised to 12 ounces
(360 ml) of beer, 5 ounces (150 ml) of wine or 1·5 ounces
(22.5 ml) of liquor. Individuals were then classified into five cat-
egories of alcohol consumption (non-drinkers: 0 drinks; light:
1–3 drinks/week; moderate: 4–7 drinks/week; moderate–
heavy: 8–13 drinks/week; heavy: 14 þ drinks/week), with
those who reported no recent alcohol consumption (including
both former drinkers and abstainers) serving as the reference
group. These classifications are in accordance with current
USDA Dietary Guidelines(1) that defines moderate alcohol con-
sumption in men as two drinks per d and heavy or high-risk
drinkers consuming more than four drinks per d or fourteen
drinks per week. Since few individuals limited their drinking
to only one type of alcohol, individuals were categorised as a
beer, wine or liquor drinker if they reported consuming any
of these alcohol beverages.
Clinical examination
The clinical examination followed a 12 h fast as described
previously(25,26). Briefly, participants completed a medical
questionnaire consisting of demographic questions, lifestyle
habits, and past and present chronic disease history. In addition,
they underwent a clinical evaluation that included body compo-
sition assessment, blood chemistry analysis, BP measurement
and a physical examination by a physician. Waist circumference
was taken at the level of the umbilicus with an inelastic tape and
classified as #102·0 or .102·0 cm according to clinical guide-
lines(27). Resting BP was measured by standard auscultatory
methods after at least 5 min of seated rest and was recorded as
the average of two or more readings separated by 2 min(28).
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Concentrations of TAG, HDL-C and glucose were measured
from the blood obtained from the antecubital venous blood
and serum was analysed using automated bioassays in the
Cooper Clinic Laboratory according to the Centers for Disease
Control and Prevention’s Lipid Standardization Program stan-
dards(28). BMI was calculated from measured weight and
height, and individuals were categorised as normal weight
(18·5–24·9 kg/m2), overweight (25·0–29·9 kg/m2) and obese
($30 kg/m2)(27). Smoking status and a personal history of
hypertension, diabetes, heart attack, stroke and cancer were
ascertained through a standardised medical questionnaire. Indi-
viduals were also stratified according to the number of MetS risk
factors present at baseline to allow for the examination of alco-
hol consumption in groups with and without co-morbidities.
Cardiorespiratory fitness
Participants completed a maximal exercise treadmill test to
assess their cardiorespiratory fitness. Cardiorespiratory fitness
was quantified as the duration of the maximal treadmill exercise
test using a modified Balke protocol(25). Participants were
encouraged to reach their maximal effort and those who did
not achieve 85 % of their age-predicted maximal heart rate
were excluded, as it was assumed that they probably had sub-
clinical medical problems and less than near-maximal effort
would lead to an underestimation of fitness. The duration of
this treadmill test is highly correlated with measured maximal
oxygen uptake in men (r 0·92)(29). Classification of fitness
level was determined on the basis of fifths of treadmill time,
with those having fitness levels in the lowest 20 % classified as
the ‘unfit’ and the remainder classified as the ‘fit’. This cut
point was used as there is no consensus for the clinical defi-
nition of being ‘unfit’ and because it has been used as a similar
guideline in previous Aerobics Center Longitudinal Study inves-
tigations, which have shown low fitness to be an independent
risk factor for various morbidity and mortality outcomes(30,31).
Statistical analyses
Baseline characteristics were summarised across the levels of
alcohol consumption and tests for linear trends were calcu-
lated using general linear models. MetS cases were defined
as individuals who met the MetS definition at any clinical
examination after baseline. The follow-up time was computed
as the difference between the date of the baseline examination
and the first follow-up event of the MetS or the last clinical
examination through 2005. A Cox proportional hazards
model was used to estimate the hazard ratios (HR) and 95 %
CI of the MetS across the categories of alcohol consumption.
Ordinal linear trends across the five categories of alcohol con-
sumption were tested using Cox regression models. In Cox
regression models, baseline age, examination year, current
smoking status and total treadmill time were considered as
potential confounders as in previous studies(21,31,32). The pro-
portional hazards assumption was tested by examining the
log–log survival plots grouped on exposure categories.
Further multivariate analyses were conducted based on
stratification by age (,55 or $55 years), BMI (,25 or
$25kg/m2), number of pre-existing MetS risk factors (0, 1 or 2)
and fitness level (fit or unfit). In the multivariate analysis for
type of alcoholic beverage (beer, wine and liquor), there
were insufficient numbers of drinkers who consumed a
single beverage type exclusively. Therefore, this analysis was
conducted separately for all individuals who consumed each
type of alcoholic beverage while adjusting for the remaining
types of alcohol consumed. Finally, the association between
alcohol consumption and the individual components of the
MetS was evaluated. To calculate multivariate HR, Cox
proportional hazards models containing each of the com-
ponents of the MetS as binary-dependent variables were
fitted to the same data which were utilised for the association
between alcohol consumption and the incidence of the MetS.
The SAS (SAS 9.1; SAS Institute, Inc.) program was used to
conduct statistical analyses. All P values were two-sided, and
P,0·05 was considered as statistically significant.
Results
From 1979 to 2005, 7483 eligible men were followed for an
average of 6·0 (SD 5·2) years for a total of 44 943 person-
years of follow-up. Descriptive characteristics of the study par-
ticipants are presented in Table 1. Significant differences in
baseline characteristics were observed between men in the
different categories of alcohol consumption except for
abdominal obesity. In general, heavier drinkers were more
likely to be older, current smokers, and have a higher BMI,
systolic and diastolic BP, fasting glucose concentrations, total
cholesterol, HDL-C and TAG concentrations.
During an average of 6·0 years of follow-up, 1578 new cases
of the MetS were observed. Overall, the incidence rate of the
MetS was 35·1 per 1000 person-years. The HR of the MetS
across the five categories of alcohol consumption levels are
presented in Table 2. Significant linear trends were observed
across the five categories of alcohol consumption (P,0·002).
In model 1, with adjustment for age, year of examination
and smoking, all levels of alcohol consumption showed a sig-
nificant inverse association with the incidence of the MetS
compared with non-drinkers. After additional adjustment for
fitness level (model 2), all associations between the levels of
alcohol consumption and the incidence of the MetS remained
significant.
Table 3 presents the HR of the individual components of the
MetS across the different categories of alcohol consumption.
No effect of alcohol consumption was observed on central
obesity, high TAG concentrations or hypertension. Moderate
(28 %), moderate–heavy (22 %) and heavy (56 %) levels of
drinking were associated with a higher risk of high fasting glu-
cose concentrations. A significant positive association was
observed between HDL-C and all levels of alcohol consump-
tion in a dose–response manner with greater levels of alcohol
consumption associated with a lower risk of low HDL-C.
In Table 4, the HR of the MetS across the five categories of
alcohol consumption are presented after stratification by age,
BMI, pre-existing MetS components, fitness level and type of
alcohol beverage consumed. Among individuals less than
55 years of age, inverse associations between alcohol
Alcohol and metabolic syndrome in US men 903
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Table 1. Baseline characteristics of the sample population
(Mean values and standard deviations)
Alcohol consumption (drinks/week)
Non-drinkers C1 (1–3) C2 (4–7) C3 (8–13) C4 (14 þ )
Mean SD Mean SD Mean SD Mean SD Mean SD P for linear trend
Subjects (n) 870 1541 1795 1509 1768
Age (years) 44·64 9·46 42·34 9·05 43·31 8·97 43·36 8·77 44·02 8·85 ,0·001
BMI (kg/m2) 25·01 2·96 25·26 2·85 25·29 2·61 25·28 2·65 25·40 2·47 0·017
Alcohol consumption (drinks/week) 0 2·05 0·77 5·38 1·12 10·23 1·61 24·39 14·48 ,0·001
Maximal treadmill time (min) 19·48 4·38 20·23 4·41 20·28 4·34 20·33 4·30 20·15 4·34 ,0·001
Waist circumference (cm) 90·12 8·58 89·70 8·65 90·11 7·96 90·35 7·77 90·89 7·76 ,0·001
Systolic blood pressure (mmHg) 117·71 12·19 117·54 11·40 117·57 12·00 118·20 11·71 119·23 12·25 ,0·001
Diastolic blood pressure (mmHg) 78·93 8·77 78·53 8·63 78·81 8·91 79·22 8·33 79·97 8·57 ,0·001
FBG (mg/l) 953·3 113 959·8 120·8 965·9 103·1 977 103·9 987·9 105·3 ,0·001
HDL-C (mg/l) 449·3 103·3 467·7 110·9 489·2 109·9 509·1 116·1 529·5 120 ,0·001
TAG (mg/l) 1047·6 617·2 1037·7 599·3 1028·7 514 1047·4 566·3 1096·5 581·3 0·005
Total cholesterol (mg/l) 2030·1 362·2 1997·3 371·6 2032·6 362·9 2057·5 366·3 2137·6 386·8 ,0·001
Current smokers (%) 7·70 11·94 13·20 17·56 21·66 ,0·001
MetS risk factors (%)
Abdominal obesity* 6·32 5·91 5·46 5·30 5·43 0·819
High blood pressure† 30·57 26·80 29·19 30·48 33·65 ,0·001
High FBG‡ 24·48 26·61 32·03 35·72 42·48 ,0·001
Low HDL-C§ 32·41 25·57 18·44 14·51 10·86 ,0·001
High TAGk 28·51 20·90 18·55 19·75 21·32 0·051
C, category; FBG, fasting blood glucose; MetS, metabolic syndrome; HDL-C, HDL-cholesterol.
* Defined as a waist circumference .102 cm.
† Defined as a systolic blood pressure $130 mmHg, a diastolic blood pressure $85 mmHg or a history of physician-diagnosed hypertension.
‡ Defined as a FBG $10 mg/l or a history of physician-diagnosed diabetes.
§ Defined as an HDL concentration , 4 mg/l.
kDefined as TAG concentrations $ 15 mg/l.
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consumption and the risk of the MetS were observed with all
categories except light consumption, while similar inverse
associations were seen in the light, moderate and moder-
ate–heavy categories in men 55 years of age and older.
Among individuals with a BMI $25 kg/m2, all levels of alcohol
consumption resulted in a lower incidence of the MetS; how-
ever, among those with a BMI ,25 kg/m2, a positive associ-
ation was seen only among moderate consumers. A separate
sub-analysis (not shown) was conducted for individuals with
BMI $30 kg/m2, but results were inconclusive due to the
small number of cases in this category. Moderate, moder-
ate–heavy and heavy alcohol consumption all resulted in an
inverse association in individuals who had two pre-existing
components for the MetS, while no significant associations
were seen in men with no pre-existing MetS components at
baseline. Significant inverse associations were observed in
both fit and unfit individuals in the moderate, moderate–
heavy and heavy alcohol consumption categories. Table 4
also presents the HR of the MetS across the five levels of
alcohol consumption after stratification by type of alcohol
beverage. Across each type of alcoholic beverage, there
were similar significant inverse associations, except with
heavy levels of liquor consumption.
Discussion
In the present prospective study of US men, we observed that
all levels of alcohol consumption provided a significant
inverse association with the development of the MetS after
taking into account several potential confounding factors. In
particular, the present study showed a significantly lower
risk of the MetS in individuals who had a greater number of
MetS risk factors present at baseline and were overweight/
obese. The benefits of alcohol also remained significant
regardless of the type of alcoholic beverage consumed.
The main finding of the present study that alcohol con-
sumption was associated with a lower risk of MetS incidence
expands upon previous epidemiological studies indicating
that light-to-moderate levels of alcohol consumption are
associated with a lower risk of the MetS in men(10,14,33,34).
However, few studies examining the relationship between
alcohol consumption and the MetS have been conducted in
prospective studies(16,19,20), and only one(16) has shown that
moderate-to-heavy alcohol consumption is associated with a
significantly lower risk of the MetS, as seen in the present
study. Although this inverse association with alcohol con-
sumption was seen in moderate drinkers, the present data
also indicate that these benefits also extend to moderate–
heavy and heavy levels of alcohol consumption. However,
these results must be interpreted with caution as these findings
do not take into account the numerous health hazards associ-
ated with heavy alcohol use (e.g. gastrointestinal and liver
diseases, cancer, intentional injuries, etc.(35)).
There are many reasons for the varying results observed
when examining the association between alcohol consump-
tion and the MetS, including factors such as sex and race/
ethnicity(20). There are several racial and ethnic biological
differences that influence alcohol metabolism(36), as well as
racial/ethnic variations in drinking quantities, patterns and
alcohol abuse disorders(37). In contrast to the present study,
Baik & Shin(19) found a linear trend between alcohol con-
sumption and the incidence of the MetS, with the quartile of
heaviest drinkers displaying a 63 % increase in relative risk.
However, this cohort consisted of Korean men and women
who have different alcohol metabolism rates(38). Therefore,
appropriate consideration must be given to race, sex and eth-
nicity when making comparisons between existing studies.
Another major confounding factor is the definition of the
MetS itself. Wakabayashi(12) found no significant associations
between alcohol consumption and the prevalence of the
MetS using International Diabetes Federation guidelines(39),
but did find a significant association in heavy drinkers when
using the National Cholesterol Education Program – Adult
Treatment Panel III guidelines(1). Other factors, such as quanti-
fication of drinking patterns(40), frequency(41) and lifetime
alcohol consumption(15), may also have a differential impact
on the development of the MetS, yet are rarely assessed
and/or controlled for in a standardised manner when examin-
ing this relationship.
Effect of alcohol on individual metabolic syndrome
components
In addition to the direct effect that alcohol consumption has
on the development of the MetS, there may be an indirect
effect through a series of relationships with each individual
Table 2. Hazard ratios of the metabolic syndrome across the levels of alcohol consumption
(Hazard ratios and 95 % confidence intervals)
Alcohol consumption (drinks/week)
C1 (1–3) C2 (4–7) C3 (8–13) C4 (14 þ )
Non-drinkers Hazard ratio 95 % CI Hazard ratio 95 % CI Hazard ratio 95 % CI Hazard ratio 95 % CI
n 870 1541 1795 1509 1768
No. of cases 248 322 333 298 377
Model 1* 1·00 (reference) 0·78 0·66, 0·93 0·64 0·54, 0·75 0·66 0·55, 0·78 0·73 0·62, 0·86
Model 2† 1·00 (reference) 0·81 0·68, 0·95 0·68 0·57, 0·80 0·70 0·59, 0·83 0·78 0·66, 0·91
C, category.
* Adjusted for age (in years), year of examination, smoking (current smoker or not).
† Additionally adjusted for maximal treadmill time (min).
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component of the MetS. Understanding these individual
relationships may be of particular use when individualising
guidance for patients who may be at risk for some com-
ponents of the MetS and not others. In the present study,
we observed no increase in the risk of hypertension with
any level of alcohol consumption. This result is consistent
with other prospective reports that have indicated no increase
in the incidence of hypertension with light-to-moderate levels
of alcohol consumption in white men(42,43). However, these
prospective studies, as well as other cross-sectional studies,
have shown a higher risk of hypertension with moderate-to-
heavy levels of alcohol consumption in comparison with
non-drinkers(12,19,33). In the present study, there was no
observed effect of alcohol consumption on either central
obesity or serum TAG concentrations. Several studies, in
agreement with the present findings, have demonstrated that
alcohol consumption is not associated with increased waist
circumference(12,14,33). A limited number of investigators
have demonstrated an increased risk of moderate and heavy
drinking on serum TAG concentrations(12,19). In contrast,
the present results suggest that no observed level of alcohol
consumption has a negative impact on serum TAG, a finding
supported by others(14). Although alcohol consumption has
been associated with decreased serum glucose concentrations,
particularly in light and moderate drinkers(14), the present
results indicate that moderate, moderate–heavy and heavy
levels of drinking are associated with an increased risk of
hyperglycaemia, which agrees with a recent study showing
increased risk in heavy drinkers(19). Paradoxically, alcohol
consumption has been related to enhanced insulin sensitivity
and lower plasma insulin concentrations(44,45), providing a poss-
ible explanation for the lower incidence of type 2 diabetes in
alcohol consumers compared with abstainers(16,46). One area
of consistent agreement involves the present findings of a posi-
tive dose–response relationship between alcohol consumption
and the risk of low HDL-C, which is in agreement with
others(12,19,44). Thus, it appears that the possible beneficial
effect of alcohol consumption is that it is associated with a
lower risk of low HDL-C, and may offset the deleterious effect
of an increased risk of high fasting glucose concentrations. It
appears that there is a need for further studies to clarify the phys-
iological mechanisms and relationship between alcohol con-
sumption and the individual components of the MetS.
Stratification based on BMI, age, fitness level and baseline
health status
All levels of alcohol consumption, except light consumers,
resulted in a reduced risk of the MetS in individuals
,55 years. In individuals $55 years of age, this association
was seen in light, moderate and moderate–heavy drinkers.
These results appear to indicate that moderate and moder-
ate–heavy alcohol consumption have a positive impact on
the incidence of the MetS across all ages in men. There was
a lower risk of MetS incidence in men who consumed
moderate, moderate–heavy and heavy levels of alcohol and
who were positive for two MetS components at baseline.
However, in men with no pre-existing MetS components atT
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Table 4. Hazard ratios of the metabolic syndrome across the levels of alcohol consumption after stratification by age, BMI, pre-existing metabolic syndrome (MetS) components, fitness level and bev-
erage type*
(Hazard ratios and 95 % confidence intervals)
Alcohol consumption (drinks/week)
C1 (1–3) C2 (4–7) C3 (8–13) C4 (14 þ )
Cases/total Non-drinkers Hazard ratio 95 % CI Hazard ratio 95 % CI Hazard ratio 95 % CI Hazard ratio 95 % CI P for interaction
Age (years) 0·72
, 55 1394/6615 1·00 (reference) 0·86 0·72, 1·03 0·70 0·58, 0·83 0·72 0·60, 0·86 0·74 0·62, 0·89
$ 55 184/868 1·00 (reference) 0·50 0·30, 0·84 0·55 0·35, 0·87 0·60 0·37, 0·95 0·69 0·45, 1·06
BMI (kg/m2) 0·16
, 25 532/3705 1·00 (reference) 1·04 0·78, 1·38 0·65 0·48, 0·88 0·81 0·61, 1·09 0·89 0·67, 1·18
$ 25 1046/3778 1·00 (reference) 0·72 0·58, 0·89 0·66 0·54, 0·81 0·64 0·52, 0·79 0·62 0·51, 0·76
No. of pre-existing MetS
components†
0·45
0 197/2237 1·00 (reference) 0·96 0·60, 1·54 0·66 0·41, 1·07 0·70 0·43, 1·13 0·92 0·58, 1·47
1 543/2926 1·00 (reference) 0·70 0·52, 0·94 0·78 0·59, 1·03 0·74 0·55, 0·99 0·67 0·51, 0·90
2 838/2320 1·00 (reference) 0·88 0·70, 1·10 0·62 0·49, 0·78 0·70 0·55, 0·88 0·75 0·60, 0·93
Fitness level‡ 0·66
Fit 1119/5978 1·00 (reference) 0·85 0·69, 1·04 0·65 0·53, 0·80 0·69 0·56, 0·84 0·71 0·58, 0·86
Unfit 459/1505 1·00 (reference) 0·81 0·59, 1·10 0·71 0·53, 0·96 0·68 0·50, 0·94 0·74 0·55, 0·99
Alcohol beverage§ NS
Beer 1167/5569 1·00 (reference) 0·75 0·62, 0·91 0·75 0·63, 0·90 0·66 0·54, 0·81 0·72 0·59, 0·88
Wine 1103/5217 1·00 (reference) 0·67 0·55, 0·82 0·67 0·55, 0·82 0·74 0·61, 0·90 0·71 0·58, 0·86
Liquor 1020/4487 1·00 (reference) 0·63 0·50, 0·78 0·72 0·60, 0·88 0·73 0·60, 0·90 0·87 0·71, 1·06
C, category.
* All stratified variables were adjusted for age (in years), year of examination, smoking (current smoker or not), number of pre-existing MetS components and maximal treadmill time (min), except variables within their same level of
stratification.
† Defined as any of the following conditions: systolic/diastolic blood pressure $140/90 mmHg or history of hypertension; fasting glucose $12·6 mg/l or history of diabetes; dyslipidaemia (total cholesterol $24 mg/l, TAG $20 mg/l or
HDL-cholesterol ,4 mg/l).
‡ Defined as the most fit (80 %) and the least fit (20 %) based on the distribution of maximal treadmill times from the study cohort.
§ Alcohol beverage stratification was created based on the distribution of use of each alcohol type with all remaining types of alcohol included as covariates in the model. No interaction test was performed between the type of
alcohol and alcohol consumption, as alcohol consumption was categorised within each type of alcohol consumption.
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baseline (i.e. those who might be considered healthier), there
was no lower risk with any level of alcohol consumption. This
result is consistent with others who found the relationship
between alcohol consumption and the MetS the strongest
among individuals with a higher number of MetS com-
ponents(33) and in men with an increased risk of diabetes(44).
A lower risk of the MetS was also seen in individuals with a
BMI $25 kg/m2 at all levels of alcohol consumption. This find-
ing is in discord with others who observed that heavy drinking
in overweight individuals was associated with a 37–115 %
increase in the risk of the MetS(19,34). Finally, all levels of alco-
hol consumption, except for light drinkers, were associated
with a lower risk of MetS incidence in both the fit and unfit
men in the study. Previous literature has established a signifi-
cant inverse relationship between cardiorespiratory fitness and
the MetS in similar cohorts(21,22). However, the mechanisms
behind the lower risk of the MetS in unfit individuals with
higher levels of alcohol consumption are unclear, and
additional work is needed to further clarify this association.
Beverage-specific effects on the metabolic syndrome
Across each type of alcoholic beverage, similar lower risks of
the MetS were observed within each category of alcohol
consumption, except with high levels of liquor consumption.
The present results support those of Djousse et al.(33) who
found that consumption of wine only, beer only, spirits only
and any combination of beverage type was associated with
risk reductions in the MetS of 68, 58, 43 and 44 %, respectively.
These findings are in contrast to those reporting that heavy
liquor consumption results in a significant increase in the
MetS(19), and that beer and wine consumption, but not liquor,
resulted in a lower prevalence of the MetS(14). The present
finding is of particular interest given that previous studies
have primarily demonstrated that the beneficial effect of alcohol
consumption has been limited to wine drinkers, individuals
who are more likely to engage in healthier lifestyles(47).
Strengths and limitations
The strengths of the present study include the use of a
comprehensive physical examination and an extensive
follow-up period in one of the largest cohort studies to investi-
gate the incidence of the MetS by alcohol consumption, as well
as our ability to stratify and adjust our models using cardiore-
spiratory fitness rather than self-reported physical activity.
Furthermore, this is one of the first prospective studies examin-
ing the relationship between alcohol consumption and the MetS
in a US male population, enhancing the internal validity of the
present findings. The limitations of the present study include:
limited external validity beyond Caucasian males of a higher
socio-economic status; possible under-reporting and sub-
sequent misclassification of alcohol consumption; the potential
misclassification of the reference group as former drinkers and
lifetime abstainers have very different alcohol consumption his-
tories. Additionally, in the stratified analyses, the relatively small
number of incident MetS cases in the older, normal-weight
(BMI , 25 kg/m2), healthy and least fit groups may have
affected the results in these groups.
Conclusion
The results of the present study suggest that alcohol consump-
tion may protect against the development of the MetS. These
findings may be particularly useful for health professionals in
providing individualised guidance to their patients with
regard to alcohol consumption and its effect on the MetS or its
individual components, and in assisting with the future
establishment of guidelines regarding the benefits and risks of
alcohol consumption.
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